Header Logo

Michael Nikolaou

Concepts (76)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
10
2023
176
1.770
 Why?
Models, Biological
7
2011
124
1.270
 Why?
Pseudomonas aeruginosa
7
2012
34
1.250
 Why?
Bacteria
3
2023
47
1.020
 Why?
Amikacin
2
2022
7
0.840
 Why?
Anti-Infective Agents
3
2011
15
0.830
 Why?
Ceftazidime
1
2022
9
0.760
 Why?
Epidemics
1
2022
4
0.750
 Why?
Communicable Diseases
1
2022
6
0.740
 Why?
Models, Theoretical
6
2022
75
0.630
 Why?
Microbial Sensitivity Tests
10
2022
96
0.580
 Why?
Acinetobacter baumannii
4
2014
12
0.570
 Why?
Thienamycins
3
2007
6
0.560
 Why?
Microbial Viability
2
2011
11
0.350
 Why?
Humans
11
2023
4936
0.340
 Why?
Scleral Buckling
1
2009
1
0.320
 Why?
Retinal Detachment
1
2009
3
0.310
 Why?
Body Fluids
1
2009
4
0.310
 Why?
Aminoglycosides
1
2008
17
0.290
 Why?
Levofloxacin
2
2011
3
0.290
 Why?
Ofloxacin
2
2011
4
0.290
 Why?
Dose-Response Relationship, Drug
4
2011
52
0.280
 Why?
beta-Lactamase Inhibitors
2
2021
10
0.260
 Why?
Drug Resistance, Bacterial
4
2012
16
0.250
 Why?
Acinetobacter Infections
2
2014
8
0.190
 Why?
HIV Infections
1
2023
104
0.170
 Why?
Lactams
1
2021
2
0.170
 Why?
Klebsiella pneumoniae
2
2012
12
0.160
 Why?
Colony Count, Microbial
2
2007
13
0.130
 Why?
Models, Statistical
2
2014
62
0.120
 Why?
Carbapenems
1
2014
7
0.110
 Why?
Escherichia coli
2
2011
111
0.090
 Why?
Imipenem
1
2012
3
0.090
 Why?
Azabicyclo Compounds
1
2012
7
0.090
 Why?
Energy Metabolism
1
2012
15
0.090
 Why?
Pneumonia, Bacterial
1
2011
5
0.090
 Why?
Computer Simulation
2
2012
161
0.090
 Why?
Neutrophils
1
2011
15
0.090
 Why?
Pseudomonas Infections
1
2011
18
0.090
 Why?
Fluoroquinolones
1
2011
4
0.090
 Why?
Staphylococcus aureus
1
2011
20
0.090
 Why?
Area Under Curve
1
2011
16
0.090
 Why?
Drug Design
1
2011
16
0.080
 Why?
Vitreous Body
1
2009
3
0.080
 Why?
Binomial Distribution
1
2009
3
0.080
 Why?
Finite Element Analysis
1
2009
8
0.080
 Why?
Viscosity
1
2009
10
0.080
 Why?
Saccades
1
2009
16
0.080
 Why?
Drug Combinations
2
2023
25
0.070
 Why?
Gentamicins
1
2008
3
0.070
 Why?
Drug Resistance, Microbial
1
2005
6
0.060
 Why?
Population Dynamics
1
2005
10
0.060
 Why?
Half-Life
1
2023
9
0.050
 Why?
Algorithms
1
2005
241
0.050
 Why?
beta-Lactamases
1
2021
12
0.040
 Why?
Time Factors
2
2012
163
0.040
 Why?
beta-Lactam Resistance
1
2014
6
0.030
 Why?
Cross Infection
1
2014
19
0.030
 Why?
Prevalence
1
2014
66
0.030
 Why?
Risk Factors
1
2014
159
0.030
 Why?
Reproducibility of Results
1
2014
318
0.020
 Why?
Drug Administration Schedule
1
2012
5
0.020
 Why?
Membranes, Artificial
1
2012
9
0.020
 Why?
Bacterial Load
1
2012
8
0.020
 Why?
Klebsiella Infections
1
2012
7
0.020
 Why?
Practice Guidelines as Topic
1
2012
19
0.020
 Why?
Immunocompromised Host
1
2011
2
0.020
 Why?
Cyclophosphamide
1
2011
3
0.020
 Why?
Aza Compounds
1
2011
2
0.020
 Why?
Quinolines
1
2011
21
0.020
 Why?
Piperacillin
1
2010
3
0.020
 Why?
beta-Lactams
1
2010
12
0.020
 Why?
Mutation
1
2011
132
0.020
 Why?
Mice
1
2011
685
0.020
 Why?
Animals
1
2011
1711
0.010
 Why?
Female
1
2011
2523
0.010
 Why?
Nikolaou's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (76)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_